Glass is in our DNA.Always has been.

KAISHA Pharma is a pharmaceutical primary glass packaging manufacturer producing ampoules, vials, cartridges and prefilled syringes in Type I borosilicate glass for injectable pharmaceutical products. Founded in 1989 and part of the Dadachanji Group, the company operates a 300,000 sq. ft. manufacturing facility on a 25-acre campus serving pharmaceutical manufacturers across regulated markets.

The company began with four glass-forming machines producing pharmaceutical glass ampoules. That focus on a single format — getting dimensional consistency, sealing performance and cosmetic quality right before adding capacity — shaped how the business grew. Ampoule manufacturing led into pharmaceutical syringes, and a technical partnership with a German company broadened its understanding of global standards for sterile primary packaging.

Today the portfolio covers four core formats. Glass ampoules are manufactured in Form B, C and D from 1 ml to 30 ml, with one point cut, colour break ring, identification rings, scoring and printing available in clear or amber glass. Pharmaceutical glass vials span crimp neck formats from 1 ml to 100 ml and screw neck formats from 1 ml to 50 ml, supplied as standard bulk, sterile, ready-to-sterilize or ready-to-fill nested systems. Ready-to-fill glass syringes are available with staked needles, luer locks and in COP/COC formats. Glass cartridges come in regular, ready-to-fill, pre-crimped, nested and dual chamber configurations for modern drug delivery devices.

What separates KAISHA Pharma from a standalone packaging vendor is the group behind it. The Dadachanji Group spans formulation development, injectable contract manufacturing, aseptic fill-finish, medical devices, engineering, automation and robotics. Sovereign Pharma runs commercial injectable manufacturing; KAISHA Lifesciences works on formulation and injectable dosage development. The container is therefore designed by an organisation that also operates filling lines — an understanding of how a vial behaves during washing, depyrogenation, filling, stoppering and crimping that is difficult to acquire from the outside.

That perspective shows in the ready-to-fill range. RTF nested vials, cartridges and syringes arrive washed, sterilised and pre-positioned in tubs or trays, removing washing and sterilisation steps from the customer's fill-finish operation and reducing changeover time on the line. For manufacturers who prefer to retain sterilisation in-house, ready-to-sterilize configurations are supplied washed and packed, ready for the customer's own cycle.

Quality systems run through every stage rather than sitting at the end of the line. Automated vision inspection monitors cosmetic quality, dimensional accuracy and neck finish. X-ray inspection is integrated into production to verify characteristics that surface inspection cannot reach. In-house ethylene oxide sterilisation keeps sterile processing inside the manufacturing ecosystem rather than depending on an external vendor's schedule. Dedicated Quality Control and Quality Assurance functions handle analytical testing, batch documentation review, statistical monitoring and product release. Details are on the quality systems page.

Customization runs across the portfolio. Containers can be specified in clear or amber Type I borosilicate glass, siliconized or non-siliconized, sulphate treated, printed, supplied with a lyophilization bottom or a chromatography finish, and packed as standard bulk, honeycomb sterile trays, nested tubs or rondo trays. Sterilisation is available by in-house ethylene oxide or by gamma irradiation. Sycure Technologies adds tamper-evident and anti-counterfeit closure options where supply chain integrity is a concern. Where a requirement falls outside the standard range, specifications are developed against the customer's filling equipment, drug product and regulatory market rather than adapted from a catalogue.

For procurement teams, R&D formulation scientists and packaging engineers evaluating a sterile glass packaging partner, KAISHA Pharma offers conventional and sterile formats, bulk through nested tub and tray configurations, clear and amber glass, and extensive customization — supported by an integrated pharmaceutical group that understands what happens to the container after it leaves the factory.